Nova Mentis Life Science (TSE:NOVA) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Nova Mentis Life Science Corp. appoints Steve Loutskou as the new President and CEO, aiming to drive future growth with his extensive entrepreneurial experience. This leadership change follows the resignation of William Rascan, who significantly contributed to the company’s development, including securing an orphan drug designation for psilocybin treatment.
For further insights into TSE:NOVA stock, check out TipRanks’ Stock Analysis page.
